Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News GB Sciences Inc GBLX

GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company. It creates patented, disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. (GBSGB). The primary focus for the development of its lead program has been in evaluating suitable... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (GREY:GBLX)

Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform

GlobeNewswire December 22, 2022

Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations

GlobeNewswire December 12, 2022

Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients

GlobeNewswire November 1, 2022

TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit

GlobeNewswire October 27, 2022

Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study

GlobeNewswire October 24, 2022

TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference

GlobeNewswire October 13, 2022

Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease

GlobeNewswire October 10, 2022

TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article

GlobeNewswire September 6, 2022

Gb Sciences is Leading Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform-PhAROS(TM)

GlobeNewswire July 19, 2022

Opinion & Analysis (GREY:GBLX)

No current opinion is available.

Bullboard Posts (GREY:GBLX)

Chief Science Officer Featured on the Cover of the Marijuana

GLTA! https://www.newswire.ca/news-releases/gb-sciences-chief-science-officer-featured-on-the-cover-of-the-marijuana-business-magazine...
RYGnews1 - October 9, 2019

GB SCIENCES SUBMITTED ONE OF THIRTY-THREE APPLICATIONS DEA..

GLTA! url=https://ryghub.com/2019/09/u-s-drug-enforcement-agency-to-expand-cannabis-research-gb-sciences-submitted-one-of-thirty-three...
RYGnews1 - September 3, 2019

Next multibagger

https://stockhouse.com/news/press-releases/2019/01/31/patient-five-cancer-free-twelve-months-after-single-anti-cancer-treatment
goregil - February 14, 2019

easy +15% today

I like :)
PeterPan80 - October 1, 2018

should get a runner

fingers crossed for everybody
PeterPan80 - September 26, 2018

NEWS! Production Licence granted!!

Green day ahead $$$ https://web.tmxmoney.com/article.php?newsid=7983475003419685&qm_symbol=GBLX:US
AletLeBains - September 25, 2018